ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,182.00
0.62%
S&P 500
5,308.13
0.09%
US Dollar vs CAD
1.3638
0.11%
Bitcoin
71,068.19
-0.53%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Bayer Ord (BYR)

  7. Bayer Ord (BYR) News

BYR

Bayer Ord (BYR)

Bayer Ord
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:BYR
DateTimeSourceHeadlineSymbolCompany
05/14/20244:15AMAlliance NewsAlliance NewsTOP NEWS: Bayer performs "as expected" with quarterly sales declineLSE:BYRBayer Ord
03/05/20246:17AMAlliance NewsAlliance NewsUPDATE: Bayer denies split-up as "not now" while swings to annual lossLSE:BYRBayer Ord
03/05/20244:13AMAlliance NewsAlliance NewsTOP NEWS: Bayer swings to annual loss on falling sales as costs riseLSE:BYRBayer Ord
03/04/20243:35AMAlliance NewsAlliance NewsBayer acquires European marketing rights to acoramidis heart treatmentLSE:BYRBayer Ord
02/19/202412:17PMAlliance NewsAlliance NewsTOP NEWS: Bayer slashes dividend in commitment to cutting down debtLSE:BYRBayer Ord
02/13/202411:07AMAlliance NewsAlliance NewsIN BRIEF: Bayer notes first patient in GenePHIT trialLSE:BYRBayer Ord
01/18/202412:09AMAlliance NewsAlliance NewsChemical firm Bayer confirms 'significant' workforce cuts in GermanyLSE:BYRBayer Ord
01/11/20248:29AMAlliance NewsAlliance NewsCORRECT: RTW Biotech's manager invests USD127 million in Ji XingLSE:BYRBayer Ord
01/08/202412:12PMAlliance NewsAlliance NewsBayer reports progress on two fronts for menopausal drug, elinzanetantLSE:BYRBayer Ord
01/08/20246:27AMAlliance NewsAlliance NewsRTW Biotech Opportunities invests USD127 million in investee Ji XingLSE:BYRBayer Ord
12/18/202311:52PMAlliance NewsAlliance NewsBayer's Monsanto to pay USD857 million over chemicals in schoolLSE:BYRBayer Ord
11/20/20234:51AMAlliance NewsAlliance NewsTOP NEWS: Bayer stock plunges on study blow for blood thinnerLSE:BYRBayer Ord
11/08/20232:40AMAlliance NewsAlliance NewsTOP NEWS: Bayer considers splitting up as quarterly loss balloonsLSE:BYRBayer Ord
11/01/20237:41AMAlliance NewsAlliance NewsBayer loses third consecutive US damages trial over Roundup weedkillerLSE:BYRBayer Ord
08/08/20232:03AMAlliance NewsAlliance NewsTOP NEWS: Bayer loss widens to nearly EUR2 billion on glyphosate hitLSE:BYRBayer Ord
07/24/20232:26PMAlliance NewsAlliance NewsTOP NEWS: Bayer cuts guidance on lower prices of glyphosate productsLSE:BYRBayer Ord
06/05/20235:39AMAlliance NewsAlliance NewsIN BRIEF: Bayer partners with Acquitas on lipid nanoparticle techLSE:BYRBayer Ord
05/11/20236:21AMAlliance NewsAlliance NewsTOP NEWS: Bayer shares fall as sales suffer on lower pricingLSE:BYRBayer Ord
02/28/20235:09AMAlliance NewsAlliance NewsBayer sees strong performance over 2022 but cautious over inflationLSE:BYRBayer Ord
02/10/20234:54AMAlliance NewsAlliance NewsIN BRIEF: Bayer's Kerendia granted label update by European CommissionLSE:BYRBayer Ord
02/08/20231:13PMAlliance NewsAlliance NewsTOP NEWS: Bayer appoints Bill Anderson as new chief executiveLSE:BYRBayer Ord
01/23/20235:02AMAlliance NewsAlliance NewsBayer's Ultravist wins contrast-enhanced mammography approval in EULSE:BYRBayer Ord
11/10/20225:10AMAlliance NewsAlliance NewsBayer buys German biotechnology start-up TargenomixLSE:BYRBayer Ord
09/09/202212:40AMAlliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:BYRBayer Ord
08/12/20226:02AMAlliance NewsAlliance NewsTribunal rules against BASF in seed businesses dispute with BayerLSE:BYRBayer Ord
08/04/20222:48AMAlliance NewsAlliance NewsTOP NEWS: Legal woes hit Bayer's profit in second quarterLSE:BYRBayer Ord
06/21/20223:53PMAlliance NewsAlliance NewsUS high court denies Bayer bid to block Roundup weedkiller lawsuitsLSE:BYRBayer Ord
05/10/20222:00AMAlliance NewsAlliance NewsTOP NEWS: Bayer makes good start to 2022 with strong quarterly salesLSE:BYRBayer Ord
04/22/20226:16AMAlliance NewsAlliance NewsIN BRIEF: Bayer seeks further approval for darolutamide in ChinaLSE:BYRBayer Ord
04/04/20221:09PMAlliance NewsAlliance NewsIN BRIEF: Bayer notes positive new data for finerenoneLSE:BYRBayer Ord
 Showing the most relevant articles for your search:LSE:BYR

Your Recent History

ASX
SRQ
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved